Elysia Poggi Davis1, Curt A Sandman, Claudia Buss, Deborah A Wing, Kevin Head. 1. Department of Psychology, University of Denver, Denver, Colorado; Departments of Psychiatry and Human Behavior, University of California Irvine, Orange, California. Electronic address: Elysia.Davis@du.edu.
Abstract
BACKGROUND: Glucocorticoids play a critical role in normative regulation of fetal brain development. Exposure to excessive levels may have detrimental consequences and disrupt maturational processes. This may especially be true when synthetic glucocorticoids are administered during the fetal period, as they are to women in preterm labor. This study investigated the consequences for brain development and affective problems of fetal exposure to synthetic glucocorticoids. METHODS: Brain development and affective problems were evaluated in 54 children (56% female), aged 6 to 10, who were full term at birth. Children were recruited into two groups: those with and without fetal exposure to synthetic glucocorticoids. Structural magnetic resonance imaging scans were acquired and cortical thickness was determined. Child affective problems were assessed using the Child Behavior Checklist. RESULTS: Children in the fetal glucocorticoid exposure group showed significant and bilateral cortical thinning. The largest group differences were in the rostral anterior cingulate cortex (rACC). More than 30% of the rACC was thinner among children with fetal glucocorticoid exposure. Furthermore, children with more affective problems had a thinner left rACC. CONCLUSIONS: Fetal exposure to synthetic glucocorticoids has neurologic consequences that persist for at least 6 to 10 years. Children with fetal glucocorticoid exposure had a thinner cortex primarily in the rACC. Our data indicating that the rACC is associated with affective problems in conjunction with evidence that this region is involved in affective disorders raise the possibility that glucocorticoid-associated neurologic changes increase vulnerability to mental health problems.
BACKGROUND: Glucocorticoids play a critical role in normative regulation of fetal brain development. Exposure to excessive levels may have detrimental consequences and disrupt maturational processes. This may especially be true when synthetic glucocorticoids are administered during the fetal period, as they are to women in preterm labor. This study investigated the consequences for brain development and affective problems of fetal exposure to synthetic glucocorticoids. METHODS: Brain development and affective problems were evaluated in 54 children (56% female), aged 6 to 10, who were full term at birth. Children were recruited into two groups: those with and without fetal exposure to synthetic glucocorticoids. Structural magnetic resonance imaging scans were acquired and cortical thickness was determined. Child affective problems were assessed using the Child Behavior Checklist. RESULTS:Children in the fetal glucocorticoid exposure group showed significant and bilateral cortical thinning. The largest group differences were in the rostral anterior cingulate cortex (rACC). More than 30% of the rACC was thinner among children with fetal glucocorticoid exposure. Furthermore, children with more affective problems had a thinner left rACC. CONCLUSIONS: Fetal exposure to synthetic glucocorticoids has neurologic consequences that persist for at least 6 to 10 years. Children with fetal glucocorticoid exposure had a thinner cortex primarily in the rACC. Our data indicating that the rACC is associated with affective problems in conjunction with evidence that this region is involved in affective disorders raise the possibility that glucocorticoid-associated neurologic changes increase vulnerability to mental health problems.
Authors: Timothy J M Moss; Dorota A Doherty; Ilias Nitsos; Deborah M Sloboda; Richard Harding; John P Newnham Journal: Am J Obstet Gynecol Date: 2005-01 Impact factor: 8.661
Authors: Mary E Coussons-Read; Marci Lobel; J Chris Carey; Marianne O Kreither; Kimberly D'Anna; Laura Argys; Randall G Ross; Chandra Brandt; Stephanie Cole Journal: Brain Behav Immun Date: 2012-03-07 Impact factor: 7.217
Authors: B P Murphy; T E Inder; P S Huppi; S Warfield; G P Zientara; R Kikinis; F A Jolesz; J J Volpe Journal: Pediatrics Date: 2001-02 Impact factor: 7.124
Authors: Michael T Treadway; Merida M Grant; Zhaohua Ding; Steven D Hollon; John C Gore; Richard C Shelton Journal: PLoS One Date: 2009-03-26 Impact factor: 3.240
Authors: Danielle A Swales; Leah A Grande; Deborah A Wing; Michelle Edelmann; Laura M Glynn; Curt Sandman; Roger Smith; Maria Bowman; Elysia Poggi Davis Journal: J Clin Endocrinol Metab Date: 2019-02-01 Impact factor: 5.958
Authors: Dae-Jin Kim; Elysia Poggi Davis; Curt A Sandman; Olaf Sporns; Brian F O'Donnell; Claudia Buss; William P Hetrick Journal: Cereb Cortex Date: 2017-11-01 Impact factor: 5.357
Authors: Melanie E Peffer; Uma R Chandran; Soumya Luthra; Daniela Volonte; Ferruccio Galbiati; Michael J Garabedian; A Paula Monaghan; Donald B DeFranco Journal: Mol Cell Biol Date: 2014-07 Impact factor: 4.272